GKZ: Counter, Differential Cell: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1977 to 2026)

U.S. FDA CDRH three-letter product classification GKZ in Hematology (21 CFR 864.5220) reconciled across 1977 to 2026.

Review 381 FDA 510(k) clearances, 82 recalled K-numbers, and 249 cumulative 1976 to 2026 CDRH recall notices for GKZ: Counter, Differential Cell on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for GKZ: Counter, Differential Cell
Regulatory MetricVerified Value
Entity ClassificationFDA 3-Letter Product Code (GKZ, Class 2)
Clinical Advisory SpecialtyHematology (Panel HE)
Cleared FDA 510(k) Submissions (1976 to 2026)381 clearances (116 California, 30.4%)
Cleared 510(k)s Linked to a Recall Notice82 K-numbers (21.52% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)249 notices (5 Class I, 240 Class II, 4 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (249 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances0 implantable (0.0%) and 0 life-sustaining
Median FDA 510(k) Review Duration106 days (90th percentile: 373 days)

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.